SCHEMBL8693625

SCHEMBL8693625

Cc1cc2ncccc2c(C)c1NC1NCCN1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATAD2 Q6PL18 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.34
NUDT1 P36639 1/20 0.34
RIPK2 O43353 1/20 0.33
ALDH1A1 P00352 1/20 0.33
LMNA P02545 1/20 0.33
HTT P42858 1/20 0.33
NPC1 O15118 1/20 0.33
HSP90AA1 P07900 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
SYK P43405 2/20 0.33
KCNH2 Q12809 1/20 0.33
AURKB Q96GD4 1/20 0.33
PRKD1 Q15139 1/20 0.33
KDM4E B2RXH2 1/20 0.33
MAPT P10636 1/20 0.33
CYP1A2 P05177 1/20 0.32
CYP1B1 Q16678 1/20 0.32
CCR1 P32246 1/20 0.32
CCR8 P51685 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8693621 0.75 CFB (0.57) LMNAKCNH2
SCHEMBL8117244 0.73 SLC40A1 (0.44) SMN1; SMN2ALDH1A1LMNAHTTNPC1
Hydrochloric Acid SCHEMBL8111469 0.72 SLC40A1 (0.43) SMN1; SMN2ALDH1A1LMNAHTTNPC1
SCHEMBL862236 0.70 NPC1 (0.54) ATAD2SMN1; SMN2NUDT1ALDH1A1HTT
SCHEMBL8692881 0.70 NR4A2 (0.47) ATAD2SMN1; SMN2NUDT1ALDH1A1LMNA
SCHEMBL29511693 0.70 NR4A2 (0.47) ATAD2SMN1; SMN2NUDT1ALDH1A1LMNA
SCHEMBL7742100 0.68 L3MBTL1 (0.38) ALDH1A1LMNANPC1HSP90AA1L3MBTL1
SCHEMBL20123930 0.68 ALDH1A1 (0.43) ATAD2SMN1; SMN2NUDT1RIPK2ALDH1A1
SCHEMBL7743448 0.66 SLC40A1 (0.40) ALDH1A1NPC1HSP90AA1L3MBTL1
SCHEMBL7742996 0.66 DDB1 (0.54) ALDH1A1HTTNPC1MAPTCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5804587-A 6-(2-imidazolinylamino) quinolines useful as alpha-2 adrenoceptor agonists THE PROCTER & GAMBLE COMPANY (US) 1998-09-08 US disclosed